These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5764792)

  • 1. Rapid sensitive method for measuring fibrinogen split-products in human serum.
    Mertens BF; McDuffie FC; Bowie EJ; Owen CA
    Mayo Clin Proc; 1969 Feb; 44(2):114-20. PubMed ID: 5764792
    [No Abstract]   [Full Text] [Related]  

  • 2. Staphylococcal clumping on microtiter plates: a rapid, simple method for measuring fibrinogen split products.
    Leavelle DE; Mertens BF; Bowie EJ; Owen CA
    Am J Clin Pathol; 1971 Apr; 55(4):452-7. PubMed ID: 5554198
    [No Abstract]   [Full Text] [Related]  

  • 3. [The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies (author's transl)].
    Kastendieck E; Barthels M
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):758-62. PubMed ID: 4437565
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP; Niewiarowski S; Myers AR; Bloch KJ; Colman RW
    N Engl J Med; 1970 Sep; 283(13):663-8. PubMed ID: 4247823
    [No Abstract]   [Full Text] [Related]  

  • 5. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    Thuot C; Perron L
    Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
    [No Abstract]   [Full Text] [Related]  

  • 6. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.
    Merskey C; Lalezari P; Johnson AJ
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):871-5. PubMed ID: 5791803
    [No Abstract]   [Full Text] [Related]  

  • 7. Tanned Red Cell Hemagglutination Inhibition Immunoassay for fibrinogen-fibrin-related antigen ("fibrinolytic degradation products") in human serum.
    Merskey C; Lalezari P; Johnson AJ
    Scand J Haematol Suppl; 1971; 13():83-5. PubMed ID: 5290706
    [No Abstract]   [Full Text] [Related]  

  • 8. A sensitive and rapid quantitive determination of fibrin split products in serum.
    Haanen C; Nováková I; Geerdink P
    Scand J Haematol; 1971; 13():107-9. PubMed ID: 5003492
    [No Abstract]   [Full Text] [Related]  

  • 9. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
    Shinada S
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
    [No Abstract]   [Full Text] [Related]  

  • 10. New nonimmunological method of measuring fibrinogen-fibrin degradation products.
    Finkelstein AE; Alexander B; Roisman F
    Thromb Res; 1974 Apr; 4(4):567-85. PubMed ID: 4428465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of fibrinogen degradation products.
    Cohen RJ
    N Engl J Med; 1970 Dec; 283(26):1465-6. PubMed ID: 5481782
    [No Abstract]   [Full Text] [Related]  

  • 13. The significance of fibrin degradation products in the blood of normal infants.
    Chessells JM
    Biol Neonate; 1971; 17(3):219-26. PubMed ID: 5550192
    [No Abstract]   [Full Text] [Related]  

  • 14. An accelerated red-cell hemagglutination inhibition immunoassay for measuring fibrinogen degradation products in human serum.
    Fischer R; Furlan M; Beck EA
    Thromb Diath Haemorrh; 1971 Oct; 26(2):311-4. PubMed ID: 5167423
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of elevated fibrin split products following thermal injury.
    Curreri PW; Wilterdink ME; Baxter CR
    Ann Surg; 1975 Feb; 181(2):157-60. PubMed ID: 1111446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis between primary and secondary hyperfibrinolysis].
    Heene DL
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):186-94. PubMed ID: 4098772
    [No Abstract]   [Full Text] [Related]  

  • 18. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
    Hahn L
    Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation monitoring in the perioperative period.
    Spiess BD
    Acta Anaesthesiol Scand Suppl; 1996; 109():77-9. PubMed ID: 8901955
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies.
    Marder VJ; Matchett MO; Sherry S
    Am J Med; 1971 Jul; 51(1):71-82. PubMed ID: 4998883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.